Multiple Myeloma and Other Plasma Cell Neoplasms
This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that hav...
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | Englisch |
| Veröffentlicht: |
Cham :
Springer International Publishing,
2018.
|
| Ausgabe: | 1st ed. 2018. |
| Schriftenreihe: | Hematologic Malignancies,
|
| Schlagworte: | |
| ISBN: | 9783319255866 |
| ISSN: | 2197-9766 |
| Online-Zugang: |
|
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 003 | SK-BrCVT | ||
| 005 | 20220618101641.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 180216s2018 gw | s |||| 0|eng d | ||
| 020 | |a 9783319255866 | ||
| 024 | 7 | |a 10.1007/978-3-319-25586-6 |2 doi | |
| 035 | |a CVTIDW11882 | ||
| 040 | |a Springer-Nature |b eng |c CVTISR |e AACR2 | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Multiple Myeloma and Other Plasma Cell Neoplasms |h [electronic resource] / |c edited by Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos. |
| 250 | |a 1st ed. 2018. | ||
| 260 | 1 | |a Cham : |b Springer International Publishing, |c 2018. | |
| 300 | |a VI, 245 p. 14 illus. in color. |b online resource. | ||
| 490 | 1 | |a Hematologic Malignancies, |x 2197-9766 | |
| 500 | |a Medicine | ||
| 516 | |a text file PDF | ||
| 520 | |a This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenström's macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myeloma and Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management. . | ||
| 650 | 0 | |a Hematology. | |
| 650 | 0 | |a Oncology . | |
| 650 | 0 | |a Immunology. | |
| 856 | 4 | 0 | |u http://hanproxy.cvtisr.sk/han/cvti-ebook-springer-eisbn-978-3-319-25586-6 |y Vzdialený prístup pre registrovaných používateľov |
| 910 | |b ZE09162 | ||
| 919 | |a 978-3-319-25586-6 | ||
| 974 | |a andrea.lebedova |f Elektronické zdroje | ||
| 992 | |a SUD | ||
| 999 | |c 238015 |d 238015 | ||